首页> 外文期刊>Anesthesiology >Neuroprotective effects of dexmedetomidine against glutamate agonist-induced neuronal cell death are related to increased astrocyte brain-derived neurotrophic factor expression
【24h】

Neuroprotective effects of dexmedetomidine against glutamate agonist-induced neuronal cell death are related to increased astrocyte brain-derived neurotrophic factor expression

机译:右美托咪定对谷氨酸激动剂诱导的神经元细胞死亡的神经保护作用与星形胶质细胞脑源性神经营养因子表达的增加有关

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Brain-derived neurotrophic factor (BDNF) plays a prominent role in neuroprotection against perinatal brain injury. Dexmedetomidine, a selective agonist of α2-adrenergic receptors, also provides neuroprotection against glutamate-induced damage. Because adrenergic receptor agonists can modulate BDNF expression, our goal was to examine whether dexmedetomidine's neuroprotective effects are mediated by BDNF modulation in mouse perinatal brain injury. Methods: The protective effects against glutamate-induced injury of BDNF and dexmedetomidine alone or in combination with either a neutralizing BDNF antibody or an inhibitor of the extracellular signal-regulated kinase pathway (PD098059) were compared in perinatal ibotenate-induced cortical lesions (n = 10-20 pups/groups) and in mouse neuronal cultures (300 μM of ibotenate for 6 h). The effect of dexmedetomidine on BDNF expression was examined in vivo and in vitro with cortical neuronal and astrocyte isolated cultures. Results: Both BDNF and dexmedetomidine produced a significant neuroprotective effect in vivo and in vitro. Dexmedetomidine enhanced Bdnf4 and Bdnf5 transcription and BDNF protein cortical expression in vivo. Dexmedetomidine also enhanced Bdnf4 and Bdnf5 transcription and increased BDNF media concentration in isolated astrocyte cultures but not in neuronal cultures. Dexmedetomidine's protective effect was inhibited with BDNF antibody (mean lesion size ± SD: 577 ± 148 μm vs. 1028 ± 213 μm, n = 14-20, P < 0.001) and PD098059 in vivo but not in isolated neuron cultures. Finally, PD098059 inhibited the increased release of BDNF induced by dexmedetomidine in astrocyte cultures. Conclusion: These results suggest that dexmedetomidine increased astrocyte expression of BDNF through an extracellular signal-regulated kinase-dependent pathway, inducing subsequent neuroprotective effects.
机译:背景:脑源性神经营养因子(BDNF)在针对围产期脑损伤的神经保护中起着重要作用。右美托咪定,α2-肾上腺素能受体的选择性激动剂,还提供针对谷氨酸诱导的损伤的神经保护作用。因为肾上腺素能受体激动剂可以调节BDNF的表达,所以我们的目标是检查在小鼠围生期脑损伤中右美托咪定的神经保护作用是否由BDNF调节介导。方法:在围产期由ibotenate诱导的皮层病变中比较了谷氨酸对BDNF和右美托咪定单独或与中和的BDNF抗体或细胞外信号调节激酶途径的抑制剂(PD098059)联合使用的保护作用(n = 10至20个幼崽/组)和小鼠神经元培养物中(300μMibotenate持续6 h)。用皮质神经元和星形胶质细胞分离培养物在体内和体外检查了右美托咪定对BDNF表达的影响。结果:BDNF和右美托咪定在体内和体外均产生明显的神经保护作用。右美托咪定在体内增强Bdnf4和Bdnf5转录以及BDNF蛋白皮层表达。在分离的星形胶质细胞培养物中,右美托咪定还增强了Bdnf4和Bdnf5的转录,并增加了BDNF培养基的浓度,但在神经元培养物中却没有。右美托咪定的保护作用在体内和PD098059中被BDNF抗体(平均病变大小±SD:577±148μm与1028±213μm,n = 14-20,P <0.001)抑制,而在分离的神经元培养物中则没有。最后,PD098059抑制了右美托咪定在星形胶质细胞培养物中诱导的BDNF释放增加。结论:这些结果表明右美托咪定通过细胞外信号调节激酶依赖性途径增加星形胶质细胞的BDNF表达,从而诱导随后的神经保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号